BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021;9:433. [PMID: 33925526 DOI: 10.3390/vaccines9050433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Rodríguez de Limia Ramírez K, Ruiz-Robledillo N, Duro-Torrijos JL, García-Román V, Albaladejo-Blázquez N, Ferrer-Cascales R. Prevalence of SARS-CoV-2 Infection in a Sample of Health Workers in Two Health Departments of the Valencian Community in Spain. Int J Environ Res Public Health 2021;19:66. [PMID: 35010325 DOI: 10.3390/ijerph19010066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hakroush S, Tampe B. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination. Front Immunol 2021;12:762006. [PMID: 34659268 DOI: 10.3389/fimmu.2021.762006] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Altawalah H. Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination. Vaccines (Basel) 2021;9:910. [PMID: 34452035 DOI: 10.3390/vaccines9080910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J 2021:postgradmedj-2021-140654. [PMID: 34362856 DOI: 10.1136/postgradmedj-2021-140654] [Reference Citation Analysis]
5 Jearanaiwitayakul T, Apichirapokey S, Chawengkirttikul R, Limthongkul J, Seesen M, Jakaew P, Trisiriwanich S, Sapsutthipas S, Sunintaboon P, Ubol S. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract. Viruses 2021;13:2202. [PMID: 34835008 DOI: 10.3390/v13112202] [Reference Citation Analysis]
6 Benis A, Banker M, Pinkasovich D, Kirin M, Yoshai BE, Benchoam-Ravid R, Ashkenazi S, Seidmann A. Reasons for Utilizing Telemedicine during and after the COVID-19 Pandemic: An Internet-Based International Study. J Clin Med 2021;10:5519. [PMID: 34884221 DOI: 10.3390/jcm10235519] [Reference Citation Analysis]
7 Tiyo BT, Schmitz GJH, Ortega MM, da Silva LT, de Almeida A, Oshiro TM, Duarte AJDS. What Happens to the Immune System after Vaccination or Recovery from COVID-19? Life (Basel) 2021;11:1152. [PMID: 34833028 DOI: 10.3390/life11111152] [Reference Citation Analysis]
8 Brennan OC, Moore JE, Moore PJA, Millar BC. Vaccination terminology: A revised glossary of key terms including lay person's definitions. J Clin Pharm Ther 2021. [PMID: 34463972 DOI: 10.1111/jcpt.13516] [Reference Citation Analysis]
9 Gallè F, Sabella EA, Roma P, Da Molin G, Diella G, Montagna MT, Ferracuti S, Liguori G, Orsi GB, Napoli C. Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy. Vaccines (Basel) 2021;9:1222. [PMID: 34835152 DOI: 10.3390/vaccines9111222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mubarak A, Almutairi S, Al-Dhabbah AD, Aldabas SY, Bhat R, Alqoufail MM, Abdel-Maksoud MA, Almanaa TN, Farrag MA, Alturaiki W. Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population. Infect Drug Resist 2022;15:3791-800. [PMID: 35875613 DOI: 10.2147/IDR.S369769] [Reference Citation Analysis]
11 Kumar A, Singh RP, Kumar I, Yadav P, Singh SK, Kaushalendra, Singh PK, Gupta RK, Singh SM, Kesawat MS, Saratale GD, Chung S, Kumar M. Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic. Antioxidants 2022;11:452. [DOI: 10.3390/antiox11030452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tosta E. The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal. Explor Immunol. [DOI: 10.37349/ei.2021.00014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sarría-santamera A, Abdukadyrov N, Glushkova N, Russell Peck D, Colet P, Yeskendir A, Asúnsolo A, Ortega MA. Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture–Recapture Approaches. Medicina 2022;58:253. [DOI: 10.3390/medicina58020253] [Reference Citation Analysis]
14 Pang W, Yang F, Zhao Y, Dai E, Feng J, Huang Y, Guo Y, Zhou S, Huang M, Zheng W, Ma J, Li H, Li Q, Hou L, Zhang S, Wang H, Liu Q, Zhang B, Zhang J. Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial. J Evid Based Med 2022;15:30-8. [PMID: 35416437 DOI: 10.1111/jebm.12465] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Plüß M, Mese K, Kowallick JT, Schuster A, Tampe D, Tampe B. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2. Front Immunol 2022;12:784145. [DOI: 10.3389/fimmu.2021.784145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Saied AA, Metwally AA, Alobo M, Shah J, Sharun K, Dhama K. Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review Article. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
17 Choudhary OP, Priyanka, Ahmed JQ, Mohammed TA, Singh I, Rodriguez-Morales AJ. Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? Hum Vaccin Immunother 2021;:1-4. [PMID: 34898381 DOI: 10.1080/21645515.2021.2007015] [Reference Citation Analysis]
18 Li Z, Liu X, Liu M, Wu Z, Liu Y, Li W, Liu M, Wang X, Gao B, Luo Y, Li X, Tao L, Wang W, Guo X. The Effect of the COVID-19 Vaccine on Daily Cases and Deaths Based on Global Vaccine Data. Vaccines (Basel) 2021;9:1328. [PMID: 34835259 DOI: 10.3390/vaccines9111328] [Reference Citation Analysis]
19 Galán-Huerta KA, Flores-Treviño S, Salas-Treviño D, Bocanegra-Ibarias P, Rivas-Estilla AM, Pérez-Alba E, Lozano-Sepúlveda SA, Arellanos-Soto D, Camacho-Ortiz A. Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico. Viruses 2022;14:154. [PMID: 35062359 DOI: 10.3390/v14010154] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 López MV, Vinzón SE, Cafferata EGA, Núñez FJ, Soto A, Sanchez-Lamas M, Afonso MJ, Aguilar-Cortes D, Ríos GD, Maricato JT, Braconi CT, Silveira VB, Andrad TM, Bonetti TCS, Ramos Janini LM, Girão MJBC, Llera AS, Gomez KA, Ortega HH, Berguer PM, Podhajcer OL. A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC. Vaccines (Basel) 2021;9:1106. [PMID: 34696219 DOI: 10.3390/vaccines9101106] [Reference Citation Analysis]
21 Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2. Vaccines (Basel) 2021;9:572. [PMID: 34205861 DOI: 10.3390/vaccines9060572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Bagno FF, Andrade LAF, Sérgio SAR, Parise PL, Toledo-teixeira DA, Gazzinelli RT, Fernandes APSM, Teixeira SMR, Granja F, Proença-módena JL, da Fonseca FG. Previous Infection with SARS-CoV-2 Correlates with Increased Protective Humoral Responses after a Single Dose of an Inactivated COVID-19 Vaccine. Viruses 2022;14:510. [DOI: 10.3390/v14030510] [Reference Citation Analysis]
23 Sugamoto K, Tanaka YL, Saito A, Goto Y, Nakayama T, Okabayashi T, Kunitake H, Morishita K. Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes. Biochemical and Biophysical Research Communications 2022;615:56-62. [DOI: 10.1016/j.bbrc.2022.04.072] [Reference Citation Analysis]
24 Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH, Jalil SMS, Jaouni SH, Kawas H, Khan WA, Vattoth AL, Al-Hashimi YA, Fares A, Zeghlache R, Zakaria D. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother 2022;:1-20. [PMID: 35113777 DOI: 10.1080/21645515.2022.2027160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
25 Jiang ZH, Wong LS, Lee CH, Hsu TJ, Yu YH. Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination. Indian J Dermatol Venereol Leprol 2022;88:445. [PMID: 35389012 DOI: 10.25259/IJDVL_819_2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Plüß M, Mitteldorf C, Szuszies CJ, Tampe B. Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma. Front Immunol 2022;13:868133. [DOI: 10.3389/fimmu.2022.868133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Klingler J, Lambert GS, Itri V, Liu S, Bandres JC, Enyindah-Asonye G, Liu X, Simon V, Gleason CR, Kleiner G, Chiu HP, Hung CT, Kowdle S, Amanat F, Lee B, Zolla-Pazner S, Upadhyay C, Hioe CE. Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals. Front Immunol 2021;12:759688. [PMID: 34987505 DOI: 10.3389/fimmu.2021.759688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
28 Marfe G, Perna S, Shukla AK. Effectiveness of COVID-19 vaccines and their challenges (Review). Exp Ther Med 2021;22:1407. [PMID: 34676000 DOI: 10.3892/etm.2021.10843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gringeri M, Battini V, Cammarata G, Mosini G, Guarnieri G, Leoni C, Pozzi M, Radice S, Clementi E, Carnovale C. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines 2022;:1-10. [PMID: 35191364 DOI: 10.1080/14760584.2022.2044799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Mosteiro-Miguéns DG, Roca DB, Domínguez-Martís EM, Vieito-Pérez N, Álvarez-Padín P, Novío S. Attitudes and Intentions toward COVID-19 Vaccination among Spanish Adults: A Descriptive Cross-Sectional Study. Vaccines (Basel) 2021;9:1135. [PMID: 34696243 DOI: 10.3390/vaccines9101135] [Reference Citation Analysis]
31 Pouresmaieli M, Ekrami E, Akbari A, Noorbakhsh N, Moghadam NB, Mamoudifard M. A comprehensive review on efficient approaches for combating coronaviruses. Biomed Pharmacother 2021;144:112353. [PMID: 34794240 DOI: 10.1016/j.biopha.2021.112353] [Reference Citation Analysis]
32 Saied AA, Metwally AA, Madkhali NAB, Haque S, Dhama K. Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review. Front Public Health 2021;9:696082. [PMID: 34485226 DOI: 10.3389/fpubh.2021.696082] [Reference Citation Analysis]
33 Dhama K, Dhawan M, Tiwari R, Emran TB, Mitra S, Rabaan AA, Alhumaid S, Alawi ZA, Al Mutair A. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Hum Vaccin Immunother 2022;:1-11. [PMID: 35258416 DOI: 10.1080/21645515.2022.2045853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Otani J, Ohta R, Sano C. Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers. Vaccines (Basel) 2021;9:1149. [PMID: 34696257 DOI: 10.3390/vaccines9101149] [Reference Citation Analysis]
35 Verdier JF, Boyer S, Chalmin F, Jeribi A, Egasse C, Maggi MF, Auvray P, Yalaoui T. Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France. BMC Nephrol 2022;23:189. [PMID: 35585512 DOI: 10.1186/s12882-022-02751-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, Grijalva MJ. COVID-19 Vaccine Hesitancy in Three Latin American Countries: Reasons Given for Not Becoming Vaccinated in Colombia, Ecuador, and Venezuela. Health Commun 2022;:1-11. [PMID: 35164624 DOI: 10.1080/10410236.2022.2035943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 del Cura-bilbao A, López-mendoza H, Chaure-pardos A, Vergara-ugarriza A, Guimbao-bescós J. Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January–May 2021, Aragon, Spain. Emerg Infect Dis 2022;28. [DOI: 10.3201/eid2803.212027] [Reference Citation Analysis]
38 Gallè F, Sabella EA, Roma P, De Giglio O, Caggiano G, Tafuri S, Da Molin G, Ferracuti S, Montagna MT, Liguori G, Orsi GB, Napoli C. Knowledge and Acceptance of COVID-19 Vaccination among Undergraduate Students from Central and Southern Italy. Vaccines (Basel) 2021;9:638. [PMID: 34200835 DOI: 10.3390/vaccines9060638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Roßmann L, Bagola K, Stephen T, Gerards AL, Walber B, Ullrich A, Schülke S, Kamp C, Spreitzer I, Hasan M, David-Watine B, Shorte SL, Bastian M, van Zandbergen G. Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response. Proc Natl Acad Sci U S A 2021;118:e2103651118. [PMID: 34561306 DOI: 10.1073/pnas.2103651118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]